Table 3.

Stratified analyses of AKI-RRT in the dexamethasone and placebo groups according to baseline kidney function^a

Baseline kidney function	Number	Number of AKI-RRT events	Dexamethasone	Placebo	RR (95% CI)	P Value
eGFR>90	602	0	—	—	—	—
eGFR 60–90	1645	0	—	—	—	—
eGFR≤60	2218	33	10 of 1090 (0.9)	23 of 1128 (2.0)	0.45 (0.20 to 0.98)	0.04
eGFR 30–59	1816	5	3 of 900 (0.3)	2 of 916 (0.2)	1.53 (0.21 to 13.0)	0.64
eGFR 15–29	300	11	4 of 147 (2.7)	7 of 153 (4.6)	0.60 (0.15 to 2.21)	0.54
eGFR<15	102	17	3 of 43 (7.0)	14 of 59 (23.7)	0.29 (0.07 to 0.99)	0.03

^aData are shown as No. (%).